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 The ninth leading cause of death in the United States is kidney disease, and hemodialysis 
is the process most commonly prescribed for treatment. It utilizes a selectively permeable 
membrane filter to remove toxins such as urea from the blood and retain necessary protein levels. 
However, traditional filters, such as cellulose triacetate, used during dialysis can be inefficient in 
terms of separation performance and reduction of fouling. Recent exploration of nanoparticles 
has resulted in the creation of Oxone Mediated TEMPO-Oxidized Nano Cellulose which has 
properties that are believed to increase hydrophilicity, increase tensile capacity, decrease 
membrane resistance and lower fouling, making it an ideal filter for dialysis. This study focuses 
on the implementation of two derivatives of these nanoparticles and how they affect the 
characterization of the membranes. Ultrafiltration and dialysis were performed using bovine 
serum albumin (BSA), lysozyme, and urea to analyze various properties of each membrane. 
These properties included flux, sieving coefficient, pore size, KoA, urea clearance, mass transfer 
coefficient, and theoretical treatment time. The first membrane, Form I, showed significant 
improvement in every property tested. The second membrane, Form II, showed slight 
improvement in each property, but it was very similar to the control, leading to the belief that it 
would not be much better than the traditional cellulose triacetate filters. The third membrane, 
50/50, was created from a mixture of the previous two, and it showed significant improvement 
similar to Form I but not quite as distinct. The Form I membrane showed the most significant 
improvement overall and was determined to be the best option for an improved dialysis filter that 







 According to the Center for Disease Control and Prevention (1), kidney disease is the  
ninth leading causes of death in the United States. This does not include the amount of people 
who currently suffer from it. Go et. al (2) states that there are an estimated 8 million American 
adults who have been diagnosed with kidney disease. A multitude of health issues arise from this 
disease due to the inability of the kidneys to filter toxins from the blood. A buildup of these 
toxins can result in unpleasant symptoms such as nausea, poor sleep, fluid retention, and 
swelling. When left untreated, it can result in death. The CDC (1) found that in 2016, over 
50,000 Americans died from kidney disease. Currently, the most common treatment to filter the 
blood artificially is hemodialysis. It does not cure the disease, but it performs the job of the 
kidneys to maintain the health of the individual. Any patient who undergoes dialysis must 
maintain an exhausting schedule. The majority of patients will receive treatment 3 times per 
week, and each treatment takes between 3 to 6 hours. This creates a difficult environment to 
maintain a job and social lifestyle while attending treatment every other day. Studies (3) have 
shown that increasing the dose, or frequency, of dialysis treatments correlates with a lower 
mortality rate. Lack of ability to attend every treatment increases the mortality rate of those with 
kidney disease, so it is vital for good health that the blood is filtered often, especially when one 
considers that the kidneys are constantly in use. 
Hemodialysis machines operate on the principle of diffusion. The kidneys work by 
diffusing high concentrations of urea out of the blood while maintaining the concentration of 




demonstrates this process. Blood is pumped out of the body and passed through small, straw-like 
tubes that are bundled together. The tubes are made of a semi-permeable material, usually  
Figure 1: The process of hemodialysis. Obtained from Chris Gralapp (4). 
cellulose or polysulfone, that have a pore size that is too small to allow blood cells and larger 
proteins to pass through. A solution containing salts and proteins called the dialysate is passed 
over the outside of the tubes. A lack of urea in the dialysate causes the toxin to be pulled through 
the filter. Additionally, if there is an excess or lack of certain salts or proteins such as sodium or 
potassium, the dialysate can readjust the balance to replace or remove them. After the blood 
passes through the filter, it is directed back into the body. This process is continuously repeated 
until the waste has been sufficiently removed from the blood. During treatment, patients also can 
undergo an ultrafiltration process to remove water from the body. Patients often experience fluid 
retention, so dialysis functions to not only remove excess waste but also excess water. 
 Cellulose is one of the most common types of materials used to create dialysis filter 
membranes (5). It is very effective for ultrafiltration in dialysis applications and is relatively 
inexpensive and easy to work with; however, improvements can be made to the material to make 
dialysis more efficient and improve the outcome of treatment. Modified cellulose membranes 




patients die as a result of dialysis treatment when the membrane has been modified in some way. 
One such method of modification is to incorporate nanocellulose particles. Collaboration with 
the University of Arkansas Medical School allowed for implementation of two types of TEMPO-
cellulose. Using TEMPO-oxidation with Oxone® as an intermediary for nanocellulose 
production, two forms of TEMPO/Oxone-oxidized cellulose nanocrystals (TOOCNs) were 
created. Form I is partially oxidized and Form II is fully oxidized. They were both found to have 
a novel crystalline structure. Figure 2 shows the general chemical structure of Form I compared 
to Form I. The Oxone of these nanocrystals is highly water soluble and cost effective. The 
production of Form I and Form II was also found to be an efficient method of crystalline 
nanocellulose production. Prior analysis of these nanoparticles involved implementation in flat 
sheet cellulose triacetate membranes. Testing found that they decreased fouling and increased 
transport properties, hydrophilic properties, and membrane strength. 
 
Previous studies (7) using various types of nanoparticles have also shown improvements in  anti-
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TEMPO-oxidized nanocellulose gives the cast material higher tensile strength and flux. These 
results lead to the belief that using nanocellulose particles can cause significantly higher flux 
with less fouling. A lower fouling membrane opens up the potential for an implanted dialysis 
filter similar to an artificial kidney. Additionally, higher flux opens up potentials to reduce 
treatment time. A study in the New England Journal of Medicine (9) found that patients who 
underwent dialysis with a higher flux rate were shown to experience lower mortality rates by 
eight percent. It must be noted that the goal is not to reduce the treatment time as much as 
possible. This study seeks to maintain membrane integrity as well as have the potential to reduce 
treatment time; further exploration of how the body reacts when undergoing dialysis with a 
higher flux must be performed to conclude how much the body can withstand. With even greater 
improvement expected from the addition of TEMPO-oxidized nanocellulose, it is believed that 
the time spent in a dialysis treatment, amount of fouling, and mortality could be reduced.  
TEMPO-oxidation, or the 2,2,6,6-tetramethylpiperidin-1-oxyl oxidation method, was 
discovered by De Noov in 1995 (10). This method was used to oxidize cellulose, and after 
surface studies were performed, it was found that the oxidation did not compromise the 
crystallinity of the material. It simply changed the surface characteristics of cellulose (11). 
Further studies are needed to characterize how the cellulose nanoparticles perform in 
ultrafiltration and dialysis, which is what this paper aims to determine. This research aims to 
determine the effect of Form I and Form II on cellulose dialysis membrane filters in both pure 
and mixed forms. It is hypothesized that a mixture of the two forms will produce a filter that 






2. Materials and Methods 
2.1 Materials 
In collaboration with The University of Arkansas for Medical Sciences (UAMS), pure 
TOCNs and Form I and Form II samples were prepared in the laboratory of Dr. Peter A. Crooks. 
These materials were used in conjunction with cellulose triacetate (CTA), N-methylpyrrolidone 
(NMP), and deionized water to create novel membranes for filtration. The proteins used for 
fouling and rejection characterization were bovine serum albumin (BSA), lysozyme, and urea. 
These are common proteins found in the blood. BSA was chosen to represent large proteins in 
the blood, lysozyme was chosen to represent medium proteins in the blood, and urea was chosen 
because it is the major waste product the is excreted from the kidneys. All membranes were 
implanted in polyvinyl chloride pipes (PVC) using underwater epoxy resin. 
2.2 Preparation of TOOCN Solution 
 Four different solutions were created for membrane casting. The first, the control, was 
created using only CTA and NMP. The solution was made using 10 wt.% CTA and 90 wt.% 
NMP. These were mixed together in a bottle and placed on a bottle roller for 5-7 days to allow 
for complete incorporation of the CTA. The second solution, Form I, was created using CTA, 
NMP, and Form I. The solution was made using 9 wt.% CTA, 90 wt.% NMP, and 1 wt.% Form 
I. To incorporate the Form I nanocrystals the NMP and Form I were blended in a 500 mL beaker 
at 6,000 rpms for 5 minutes in a water bath. Then, the solution was placed in a sonicator at 500 
watts at 20 kHz for 5 minutes with 20 second intervals of sonication followed by 10 seconds of 
no sonication. After sonication, the TOOCNs were fully dispersed in solution. This was run 




added to a roller bottle with the CTA and placed on a bottle roller for 5-7 days. This process was 
repeated with the other two types of solutions but with adjusted concentrations of Form I and 
Form II. The third solution, 50/50, was prepared using CTA, NMP, and Form I and II. The 
solution was made using 9 wt.% CTA, 90 wt.% NMP, 0.5 wt.% Form I, and 0.5 wt.% Form II. 
The same mixing procedure was followed that was used for Form I. The fourth solution, Form II, 
was prepared using CTA, NMP, and Form II. The solution was made with 9 wt.% CTA, 90 wt.% 
NMP, and 1 wt.% Form II. This solution was mixed with the same procedure as Form I and 
50/50.  
2.3 Membrane Casting 
 Membranes were created with non-solvent phase induced separation hollow fiber casting. 
A water bath set at 35 ℃ was filled so the fibers would be fully immersed as they traveled the 
length of the bath. A bore solution containing 15 wt.% NMP and 85 wt.% deionized water was 
utilized. A spinneret was used to extrude the hollow fibers. It was set to obtain a 200 µm 
thickness of the membranes. The polymer solutions were passed through the outer layer of the 
spinneret at a pressure of 25 psi and the bore was passed through the spindle at a pressure of 1-2 
psi to create a hollow tube. The spinneret was set at a 5 cm height above the water level to obtain 
consistent time spent passing into the bath. As the solutions passed through the water bath, phase 
inversion occurred. The fibers were collected in a roll at a rate of 168 cm per minute until casting 
was complete. Immediately after completion, the fibers were placed in a hot water bath at 87-89 
℃ for 3 minutes to heat treat. This heat treatment set the membrane to strengthen them and 
ensure high quality. After heat treatment, they were placed in a container filled with room 





2.4 Module Assembly 
 For each dialysis run, a new module had to be created. For each module, PVC pipes were 
assembled in the fashion shown in Figure 3 below. Figure 3 shows one of the completed 
hemodialysis modules created for testing. Each module contained 20 fibers. The fibers were 
inserted into the PVC apparatus and glued into place with underwater epoxy resin. This glue was 
used to seal the ends of the apparatus so no leaking would occur during testing. About 3 mL of 
glue was used for each end. After the glue was fully solidified, the ends were cut to create an 
even surface and threaded caps were added to the module to create the completed module. These 
were stored in a room temperature deionized water bath until ready for testing. Fiber length was 
measured to use in future calculations. 
Figure 3: Example of hemodialysis module used for running tests.  
2.5 Dialysis and Ultrafiltration Testing 
 To begin testing, the module was hooked up to allow solutions to pass through the fibers. 
The four ends were attached to allow the direction of the solution passing through the fibers to be 
opposite the direction of the water passing outside of the fibers. Pressure dampers were used to 




passed through the dialysate side (outside) of the membranes and water was passed through the 
feed side (inside) of the membranes. This was run for one hour at 1-2 psi to stabilize the 
membrane. The dialysate was run at a flow rate of 300 mL/min and the feed was run at a flow 
rate of 200 mL/min. The transmembrane pressure was kept consistent. During the hour of 
stabilization, the feed solutions were made. For BSA and lysozyme runs, the concentration was 1 
mg/mL. Each solution was made with 800 mL of water and 800 mg of protein. For the urea runs, 
the concentration was 2 mg/mL. Each solution was made with 800 mL of water and 1,600 mg of 
urea. These solutions were mixed for their respective tests and hooked up to the testing 
apparatus. Once the pure water stabilization was finished, the setup was switched over to 
ultrafiltration, which involved turning off the dialysate. The feed was maintained at a flow rate of 
200 mL/min. Three water samples were collected from the permeate. Each sample was collected 
for 90 seconds. They were weighed for flux data calculation. After three samples were collected, 
the feed solution was switched to the protein solution to obtain ultrafiltration data on the protein. 
Three more samples were collected and weighed. After each sample collection, a 
microcentrifuge tube sample was collected from the feed in, feed out, and permeate to measure 
filtration. After ultrafiltration, the dialysate was turned back on to run dialysis with the protein. 
Three flow rates were used to model different rates of dialysis. The first flow rate was run at a 
200 mL/min feed rate and a 300 mL/min dialysate rate. Feed in, feed out, and dialysate out 
samples were collected to measure filtration. The second flow rate was run at a 300 mL/min feed 
rate and a 500 mL/min dialysate rate. Samples were gathered again. The third flow rate was run 
at a 400 mL/min feed rate and a 500 mL/min dialysate rate. Samples were also gathered for this. 
After samples were collected, the machine was turned off and the module was disconnected. A 




2.6 Sample Testing 
 The samples collected during dialysis and ultrafiltration were tested using a BioTek 
Epoch Multi-Volume Spectrophotometer. A UV- transparent 96-well plate was utilized. Samples 
were pipetted in triplicate in 100 µL increments into the well plate. The absorbance was run at 
280 nm for the BSA and lysozyme samples. The urea samples were prepared with a 
QuantiChrom Urea Assay Kit and run at 520 nm in a standard polystyrene 96-well plate.  
2.7 ESEM Imaging 
 Images were taken using a Philips XL30 ESEM machine to characterize the membrane 
morphology. They were taken at 65X, 150X, and 350X magnification. Cross sections of the 
fibers were prepared using a freeze-cracking method. Images were taken of the cross sections as 
well as the outside of the fibers.  
3. Results and Discussion 
3.1 Membrane Flux, Pore Size, and Sieving Coefficient 
 Traditional cellulose filters do not show improvement in flux data due to a lack of 
improvements being made to the membranes.  However, implementation of the nanoparticles 
improves this property greatly. Analysis of the flux data obtained from ultrafiltration was done 
using Equation 1 shown below, where 𝑸𝑼𝑭 refers to the volumetric ultrafiltration rate and A 
refers to the area of the membrane. 𝑷𝒊𝒏𝒍𝒆𝒕 is the pressure at the inlet of the system and 𝑷𝒐𝒖𝒕𝒍𝒆𝒕 is 
the pressure at the outlet of the system. This equation was obtained from Kim et. al (12). 









The sieving coefficient (𝑺𝑶) of each membrane was determined using Equation 2 (12), where 
𝑪𝒇 is the concentration of the filtrate and 𝑪𝒑 is the concentration of the permeate. The  




experimental data was plotted against each molecular weight for urea, lysozyme, and BSA in 
Figure 4 below. Additionally, the curves shown in the graph are theoretically modelled data. As  
Figure 4: Experimental (points) and Theoretical (lines) sieving coefficients (So) plotted on the y-
axis, and protein molecular weight plotted on the x-axis.  
shown, the theoretical data fits the experimental data well. Forms I and II show similar 
characteristics to the control. However, 50/50 fell slightly short in performance with BSA. This 
is likely due to the increased pore size, which is calculated below. Due to these results and 
because BSA is such an important protein in the blood, 50/50 may not perform quite as 
efficiently in a dialysis treatment in this aspect. Additionally, pore size of each membrane was 
determined with Equations 3 and 4. Equation 3 determines the theoretical solute radius (𝑹𝒔) of  
Equation 3: 𝑹𝒔 = 𝟑. 𝟏 × 𝟏𝟎
−𝟏𝟏(𝑴𝑾)
𝟎.𝟒𝟕𝟕𝟓𝟐 































each protein used. 𝑴𝑾 refers to their molecular weight. Equation 4 is a hydrodynamic model 
(12) that uses the values calculated from the sieving coefficient where λ is the ratio of the solute  
Equation 4: 𝑺𝑶 = (𝟏 − 𝝀
𝟐)[𝟐 − (𝟏 − 𝝀𝟐)]𝒆𝒙𝒑(−𝟎. 𝟕𝟒𝟔𝝀𝟐) 
radius to the pore radius. The pore radius was determined by the minimization of the sum of the 
squared residuals between the model (equation 4) and the data. The values obtained for flux data 
and pore size are displayed in Table 1 below. Membrane area, radius, and thickness can be found 
in this table as well. As determined by the table, each membrane had relatively the same area,  
Table 1: Experimentally obtained values for membrane area, radius, thickness, flux, and pore 
size of the four variations. 
 A (m2) R (µm) δ (µm) KUF Pure Water 
(L/hr/m2/PSI) 
Rp (nm) 
Control 0.0115 568 192 109 9.0 
Form I 0.0112 578 211 144 9.8 
Form II 0.0118 554 229 111 9.9 
50/50 0.0105 513 226 121 11.6 
 
radius, and thickness with some variation in sizes. This uniformity was produced by casting all 
membranes with the same spinneret; however, some human error can occur when adjusting the 
spinneret, which may have caused the slight variations. These values were used to calculate the 
flux and pore size of each membrane. Form I and 50/50 had a significantly higher flux than 
either the control or Form II. Both would be able to perform dialysis with an increased flow rate 
to speed up the process. Additionally, 50/50 had a larger pore size than any of the other 
membranes. A larger pore size would allow for increased filtration without clogging of the pores, 
resulting in a decrease in fouling. However, this also may result in more passage of larger 




molecular weight for urea, lysozyme, and BSA, respectively. Forms I and II show similar 
characteristics to the control. However, 50/50 fell slightly short in performance with BSA. This 
is likely due to the increased pore size. Due to these results and because BSA is such an 
important protein in the blood, 50/50 may not perform quite as efficiently in a dialysis treatment 
in this aspect. 
3.2 Urea Characterization 
 Although traditional cellulose triacetate membranes are able to filter urea, they tend to do 
so at a lower clearance. 𝑲𝒐𝑨 is the mass transfer area coefficient, otherwise known as the 
theoretical clearance at infinite blood and dialysate flow rates. 𝑲𝒐𝑨 is determined using Equation 
5, Fick’s Law, below. N represents the solute transport rate, which was calculated using Equation 
6, where Q represents the flow rate and C represents the concentration. Subscript f represents 
feed, subscript d represents dialysate, subscript o represents out, and subscript i represents in. A 
represents the area, and ∆𝑪𝑴 represents the log mean concentration difference, which was 
calculated using Equation 7. Subsequently, the clearance 𝑲 can be determined from Equation 8. 
The values calculated for each membrane can be found in Table 2 below. 
Equation 5: 𝑵 = 𝑲𝒐𝑨𝑨(∆𝑪𝑴) 
Equation 6: 𝑵 =  𝑸𝒇(𝑪𝒇𝒊 − 𝑪𝒇𝒐) = 𝑸𝒅(𝑪𝒅𝒐 − 𝑪𝒅𝒊) 














Form I and 50/50 both had a significantly higher KoA value than the control and Form II. They 
would both perform well during high-efficiency dialysis where the flow rate is increased 
Table 2: Experimentally determined values of urea clearance (K) and the mass transfer 
coefficient (ko) for each membrane derivative. 𝑲𝒐𝑨 is the mass transfer area coefficient. ε/τ is the 
porosity/tortuosity and was calculated using Equations 8-10. 
 𝑲𝒐𝑨 Kexperimental 
(mL/min) 
ko (µm/s) ε/τ 
Control 968.3048 9.431863 14.02224 3.1 
Form I 1995.788 20.81781 32.80209 7.9 
Form II 1176.942 14.50435 21.31135 5.6 
50/50 1527.56 16.21754 26.90686 6.8 
 
significantly to perform filtration within the typical 4-hour time period. Additionally, the 
experimentally determined urea clearance was calculated with Equation 5 using the respective 
data that was collected. It can also be found in Table 2. Form I had the highest urea clearance. 
Form II and the 50/50 membranes both had improved urea clearance as well when compared to 
the control. All three filters would be able to filter out urea more efficiently than the control 
while fouling less. Form I would be able to filter out urea the most efficiently out of the three 
options. The mass transfer coefficient, 𝒌𝒐, which represents the rate of transfer of the particles, 
was calculated with Equation 9 (12) below. 𝜺 represents the membrane porosity, 𝝉 represents the  




membrane tortuosity (curvature of pores), 𝜹𝒎 represents membrane thickness, and 𝑫𝒆𝒇𝒇 
represents solute diffusivity. This value was calculated from Equation 10 (12). 𝝀 refers to the 







= (𝟏 − 𝝀𝟐)[𝟏 − 𝟐. 𝟖𝟒𝟖𝝀 + 𝟑. 𝟐𝟔𝟗𝝀𝟐 − 𝟏. 𝟑𝟔𝟏𝝀𝟑] 
free solution. It was determined using Equation 11 (12), where 𝒌𝑩 is the Boltzmann constant, 𝑻 
is the absolute temperature, and 𝝁 is the solution viscosity. All values calculated can be found in  




Table 2. Once the ratio of porosity to tortuosity (ε/τ) was known, a theoretical model of the mass 
transfer coefficient was developed to show the relationship between the mass transfer coefficient 
and the molecular weights of urea, lysozyme, and BSA, which can be found in Figure 5. Based 
on the values calculated, both Form I and 50/50 have a higher rate of transfer of particles. Form 
II also showed improvement but not to the same extent.  
Figure 5: Theoretically determined mass transfer coefficient (ko) plotted on the y-axis and 
protein molecular weight plotted on the x-axis. 






































Figure 6: Experimentally determined mass transfer coefficient (ko) curve plotted on the y-axis 
and sieving coefficient (So) plotted on the x-axis.  
Additionally, mass transfer coefficients were plotted against the sieving coefficients to create a 
theoretical model to determine pore structure. This can be found in Figure 6 above. Based on the 
shape of the curve, the membranes have a symmetric pore structure. Additionally, a 
porosity/tortuosity ratio was obtained. The pores were all uniform and did not curve or twist 
throughout the membrane. All three membranes with the TOOCNs showed an increase in the 
ratio.  
3.3 Theoretical Urea Clearance and Treatment Time 
 Theoretical urea clearance can be compared to the actual values to determine theorical 
model validity. The theoretical urea clearance was calculated by simultaneously solving Fick’s 
law, the log mean concentration difference, and a mass balance to express the ratio 
𝑲
𝑸𝒇
 as a 
function of two dimensionless parameters, neither of which involves solute concentration, 
















































The theoretically determined values can be found in Table 3. When compared to the 
experimental values in Table 2, it can be determined that the theoretical values are nearly 




% error KTheoretical 
(mL/min) 






Control 9.184794 2.7 210.888 3.98 
Form I 20.62068 1.0 284.4885 2.95 
Form II 12.19495 18.9 253.8926 3.31 
50/50 15.90278 2.0 257.8775 3.26 
 
identical to experimental values. Additionally, percent error can be found for each of the 
theoretical calculations. These all show low values with the exception of Form II. This can be 
attributed to the existence of separation facilitating attributes not explored in this investigation, 
such as charge. From the theoretical clearance values, the theoretical treatment time was 
calculated in accordance with the US National Kidney Foundation Kt/V target. In this equation, a 
70 kg person, at 60% water weight, must reach a Kt/V of 1.2. It was found that Form I decreased 
treatment time the most drastically. 50/50 and Form II also showed a decrease in treatment time, 
while the control showed the typical treatment time average. However, it must be noted again 
that the goal is not to reduce treatment time, but to simply show the ability of the membranes to 





3.4 ESEM Images 
 Traditional cellulose triacetate membranes form a single support pore layer. ESEM 
images were taken to determine the pore structure of the membranes with the nanoparticles. The 
images obtained from ESEM can be found in Figure 7. Each membrane formed a unique pore 
structure. It can be observed that the control (a) formed a single layer of uniform support pores. 
All three of the other membranes formed a double layer of support pores. Form I (b) had the  
Figure 7: ESEM images of (a) the control, (b) Form I, (c) 50/50, and (d) Form II to show pore 
structure and membrane size at a 200 µm scale. 
smallest outer layer of support pores. 50/50 (c) had a double layer of support pores that had some 
irregularity. Form II had a double layer of support pores with the most uniformity. The addition 
of a double layer of support pores could explain the increase in flux and urea clearance, as well 
as suggest that the nanocellulose material may also act as a pore former. The more porosity 
available, the more easily things can pass through. Additionally, it can be noted that the support 










relationship seen in the theoretically defined pore radius showing that the membrane has the 
capacity to filter larger molecules with more ease than the control and current dialysis filters. 
4. Conclusion 
 Each of the three membrane derivatives showed marked improvements when compared 
to the control, the cellulose triacetate membrane. All showed an increase in flux, mass transfer 
area coefficient, and urea clearance. Additionally, all three showed a decrease in the theoretical 
treatment time. The 50/50 membrane had been hypothesized to show the greatest increase in all 
aspects of dialysis treatment. However, while it did show a relatively significant improvement to 
the control, Form I was the filter that showed the greatest improvement. The only data where the 
50/50 was improved from Form I was pore size. 50/50 would allow for larger particle filtration 
with minimized fouling. However, that caused a decrease in sieving coefficient, so valuable 
proteins may be lost. Form II also showed a notable improvement in many aspects, but it was 
very similar to the control. The properties of each membrane also suggests that any of the three 
would foul less during dialysis. Each membrane showed unique improvements, but Form I 
appeared to be the ideal filter out of the three derivatives. 
5. Future Work 
 In the future, the membranes need to be tested using real blood to determine how they 
perform under real dialysis conditions. Animal blood, most likely pig blood, would be used to 
determine this. Additionally, exploration of different ratios of nanoparticles may be pursued to 
obtain a mix of the different properties of each membrane to find the ideal filter for a dialysis 
setting. A potential direction to pursue would be the creation of an implantable filter. Most filters 




of these membranes suggest they would withstand filtration in vivo for an extended period of 
time without losing functionality. Perhaps a filter could be designed using these nanoparticles 
that could act as an artificial kidney. 
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